Affiliation:
1. Sunnybrook Health Science Centre
2. Women's College Hospital
3. St. Michael's Hospital
Abstract
Abstract
Background:
People with substance use disorder (SUD) are at risk of complications of drug use and frequent hospitalization, and may continue to use substances during admission to acute care. Acute care harm reduction strategies including oral or injectable prescription opioids may aid in care retention and improve health outcomes in this patient population.
Case Presentation:
A 58 year-old woman with refractory opioid use disorder was admitted to hospital for management of dysphagia secondary to esophageal stricture. She received injectable opioid agonist therapy using a continuous ambulatory drug delivery (CADD) pump in order to facilitate completion of her hospital admission.
Conclusions:
The patient successfully received acute medical care with the use of a CADD pump for consistent, patient-controlled opioid administration, with the support of an interdisciplinary team and by respecting the patient’s own substance use goals.
Publisher
Research Square Platform LLC
Reference11 articles.
1. Supervised consumption services for acute care hospital patients;Dong KA;CMAJ,2020
2. Harm Reduction. Accessed March 30, 2023. https://ontario.cmha.ca/harm-reduction/
3. Management of opioid use disorders: A national clinical practice guideline;Bruneau J;CMAJ,2018
4. On behalf of: Changing Circumstances Surrounding Opioid-Related Deaths in Ontario during the COVID-19 Pandemic;Ontario Drug Policy Research Network
5. Injectable opioid agonist treatment for opioid use disorder: A national clinical guideline;Fairbairn N;CMAJ,2019